| pubmed-article:21315558 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21315558 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:21315558 | lifeskim:mentions | umls-concept:C0014544 | lld:lifeskim |
| pubmed-article:21315558 | lifeskim:mentions | umls-concept:C0028945 | lld:lifeskim |
| pubmed-article:21315558 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:21315558 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
| pubmed-article:21315558 | pubmed:issue | 1-2 | lld:pubmed |
| pubmed-article:21315558 | pubmed:dateCreated | 2011-3-11 | lld:pubmed |
| pubmed-article:21315558 | pubmed:abstractText | Many patients with an oligodendroglioma (OD) experience seizures, some of which become refractory to anti-epileptic drugs (AEDs). This study aims (1) to quantify the rate of seizures and medically refractory epilepsy in patients with ODs; and (2) to determine if there is any association between short-term and long-term survival, and the presence and drug-responsiveness of seizures. | lld:pubmed |
| pubmed-article:21315558 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21315558 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21315558 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21315558 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21315558 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:21315558 | pubmed:issn | 1872-6844 | lld:pubmed |
| pubmed-article:21315558 | pubmed:author | pubmed-author:CairncrossJ... | lld:pubmed |
| pubmed-article:21315558 | pubmed:author | pubmed-author:MegyesiJoseph... | lld:pubmed |
| pubmed-article:21315558 | pubmed:author | pubmed-author:HammondRobert... | lld:pubmed |
| pubmed-article:21315558 | pubmed:author | pubmed-author:MacdonaldDavi... | lld:pubmed |
| pubmed-article:21315558 | pubmed:author | pubmed-author:LeeDonald HDH | lld:pubmed |
| pubmed-article:21315558 | pubmed:author | pubmed-author:MirsattariSey... | lld:pubmed |
| pubmed-article:21315558 | pubmed:author | pubmed-author:ChongJaron... | lld:pubmed |
| pubmed-article:21315558 | pubmed:copyrightInfo | Copyright © 2011 Elsevier B.V. All rights reserved. | lld:pubmed |
| pubmed-article:21315558 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21315558 | pubmed:volume | 94 | lld:pubmed |
| pubmed-article:21315558 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21315558 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21315558 | pubmed:pagination | 39-44 | lld:pubmed |
| pubmed-article:21315558 | pubmed:meshHeading | pubmed-meshheading:21315558... | lld:pubmed |
| pubmed-article:21315558 | pubmed:meshHeading | pubmed-meshheading:21315558... | lld:pubmed |
| pubmed-article:21315558 | pubmed:meshHeading | pubmed-meshheading:21315558... | lld:pubmed |
| pubmed-article:21315558 | pubmed:meshHeading | pubmed-meshheading:21315558... | lld:pubmed |
| pubmed-article:21315558 | pubmed:meshHeading | pubmed-meshheading:21315558... | lld:pubmed |
| pubmed-article:21315558 | pubmed:meshHeading | pubmed-meshheading:21315558... | lld:pubmed |
| pubmed-article:21315558 | pubmed:meshHeading | pubmed-meshheading:21315558... | lld:pubmed |
| pubmed-article:21315558 | pubmed:meshHeading | pubmed-meshheading:21315558... | lld:pubmed |
| pubmed-article:21315558 | pubmed:meshHeading | pubmed-meshheading:21315558... | lld:pubmed |
| pubmed-article:21315558 | pubmed:meshHeading | pubmed-meshheading:21315558... | lld:pubmed |
| pubmed-article:21315558 | pubmed:meshHeading | pubmed-meshheading:21315558... | lld:pubmed |
| pubmed-article:21315558 | pubmed:meshHeading | pubmed-meshheading:21315558... | lld:pubmed |
| pubmed-article:21315558 | pubmed:meshHeading | pubmed-meshheading:21315558... | lld:pubmed |
| pubmed-article:21315558 | pubmed:meshHeading | pubmed-meshheading:21315558... | lld:pubmed |
| pubmed-article:21315558 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21315558 | pubmed:articleTitle | Do epileptic seizures predict outcome in patients with oligodendroglioma? | lld:pubmed |
| pubmed-article:21315558 | pubmed:affiliation | Department of Clinical Neurological Sciences, University of Western Ontario, London, Canada. smirsat2@uwo.ca | lld:pubmed |
| pubmed-article:21315558 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21315558 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
